structure of 2-[5-chloro-2-(chloromethyl)-1h-1,3-benzodiazol-1-yl]ethan-1-ol

2-[5-chloro-2-(chloromethyl)-1h-1,3-benzodiazol-1-yl]ethan-1-ol

CAS No.: 1000932-85-3
M. Wt: 245.10
M. Fa: C10H10Cl2N2O
InChI Key: FPBDSBPLKVZYGY-UHFFFAOYSA-N

Names and Identifiers of 1000932-85-3

CAS Number

1000932-85-3

MDL Number

MFCD09971412

IUPAC Name

2-[5-chloro-2-(chloromethyl)-1H-1,3-benzodiazol-1-yl]ethan-1-ol

InChI

InChI=1S/C10H10Cl2N2O/c11-6-10-13-8-5-7(12)1-2-9(8)14(10)3-4-15/h1-2,5,15H,3-4,6H2

InChIKey

FPBDSBPLKVZYGY-UHFFFAOYSA-N

Canonical SMILES

OCCN1C2=CC=C(Cl)C=C2N=C1CCl

UNSPSC Code

12352100

Physical and chemical properties of 1000932-85-3

Acidity coefficient

14.50±0.10(Predicted)

Boiling Point

435.7±35.0 °C(Predicted)

Density

1.45±0.1 g/cm3(Predicted)

H Bond Acceptors

2

H Bond Donors

1

LogP

2.05753126966667

Molecular Formula

C10H10Cl2N2O

Molecular Weight

245.10

Safety Information of 1000932-85-3

Pictograms

Signal Word

Warning

Safety Data Sheet

Supports customized editing of SDS information and downloading in PDF documents.

Applications of 1000932-85-3

The applications of 2-[5-chloro-2-(chloromethyl)-1H-1,3-benzodiazol-1-yl]ethan-1-ol extend across various fields:

  • Pharmaceuticals: Due to its potential biological activity, it may serve as a lead compound in drug development.
  • Chemical Research: It can be utilized as an intermediate in organic synthesis, particularly in the development of more complex heterocyclic compounds.
  • Material Science: Its unique properties may lend themselves to applications in developing new materials with specific functionalities.

Interaction Studies of 1000932-85-3

Interaction studies are crucial for understanding how 2-[5-chloro-2-(chloromethyl)-1H-1,3-benzodiazol-1-yl]ethan-1-ol interacts with biological targets. Preliminary data suggest potential interactions with enzymes or receptors involved in cellular signaling pathways. Further studies are necessary to elucidate these interactions fully and assess their implications for therapeutic use.